Global Liposomal Drug Delivery Market Trends And Strategies Of Major Players In The Liposomal Drug Delivery Market 2021-2030
22 Oct, 2021
The liposomal drug delivery devices market consists of sales of liposomal drug delivery devices and related services by entities (organizations, sole traders, and partnerships) that manufacture liposomal drug delivery devices. Liposomes are microscopic colloidal spheres that are used to deliver drug molecules to the site of action. Liposomal drug delivery devices are used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics, and home care settings.
Global Liposomal Drug Delivery Market Size And Drivers:
The global liposomal drug delivery devices market is expected to grow from $3.30 billion in 2020 to $3.64 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.39 billion in 2025 at a CAGR of 10%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the liposomal drug delivery devices market during the forecast period.
Request For A Sample For The Global Liposomal Drug Delivery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3349&type=smp
Trends In The Global Liposomal Drug Delivery Market
Several big companies are undertaking various strategic initiatives such as collaborations and new product development, which is likely to become a major trend in the liposomal drug delivery devices market. Various companies are coming together to develop liposomal drug delivery systems to expand their product portfolio and operations worldwide. For instance, in June 2018, Virpax Pharmaceuticals, Inc., a company based in West Chester, Pennsylvania engaged in manufacturing drug delivery systems, signed a license agreement with LipoCure to manufacture pain management products using the company’s liposome drug delivery technology. Virpax Pharmaceuticals, Inc. develops pharmaceuticals products for pain management using new drug delivery systems. In March 2020, FUJIFILM Corporation announced its decision to offer contract services of process development and manufacturing of liposome formulations to its partners seeking drug delivery formulations that are designed to deliver the therapeutic to the affected sites.
Global Liposomal Drug Delivery Market Segments:
The global liposomal drug delivery market is further segmented –
By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others
By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Others
By Geography: The global liposomal drug delivery market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Liposomal Drug Delivery Market At:
https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report-2020-30-covid-19-growth-and-changeLiposomal Drug Delivery Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides liposomal drug delivery market overviews, analyzes and forecasts market size and growth for the global liposomal drug delivery market, liposomal drug delivery market share, liposomal drug delivery market players, liposomal drug delivery market segments and geographies, liposomal drug delivery market’s leading competitors’ revenues, profiles and market shares. The liposomal drug delivery market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.